Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Classes and Categories01:25

Drug Classes and Categories

1.8K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.8K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

146
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
146
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

185
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
185
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

151
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
151
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

413
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
413
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

368
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
368

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The AadR-FixK hierarchy coordinates iron-responsive metabolism via Fur-family regulators in <i>Rhodopseudomonas palustris</i> TIE-1.

bioRxiv : the preprint server for biology·2026
Same author

Artificial Intelligence in single-cell and spatial transcriptomics data analyses.

Progress in molecular biology and translational science·2026
Same author

Correlation between liver stiffness measurement and hepatocellular carcinoma risk: A case control study.

Bioinformation·2026
Same author

Reply to Roepe, "The collective creativity of Drs. Baro, Pooput, and Callaghan".

Antimicrobial agents and chemotherapy·2026
Same author

Differential expression of mitochondria-associated genes in clinical samples of Plasmodium falciparum showing severe manifestations.

BMC genomics·2026
Same author

Molecular Docking and MD Modeling Techniques for the Development of Novel ROS1 Kinase Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 17, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K

Classifying opioid use disorder based on diagnostic criteria items using cluster analysis.

Shweta Birla1, Vinit Patel2, Dinesh Gupta1

  • 1Translational Bioinformatics Group, International Centre for Genetic Engineering Biotechnology (ICGEB), New Delhi, India.

Industrial Psychiatry Journal
|May 16, 2025
PubMed
Summary

This study identified two distinct clusters of opioid use disorder (OUD) based on severity, not symptom similarity. These findings reveal clinically relevant subgroups for better understanding OUD patient profiles.

Keywords:
Clinical relevanceDiagnostic and Statistical Manual of Mental Disorderscluster analysisopioid-related disordersphenotype

More Related Videos

Large-scale Reconstructions and Independent, Unbiased Clustering Based on Morphological Metrics to Classify Neurons in Selective Populations
12:27

Large-scale Reconstructions and Independent, Unbiased Clustering Based on Morphological Metrics to Classify Neurons in Selective Populations

Published on: February 15, 2017

6.9K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

1.9K

Related Experiment Videos

Last Updated: May 17, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
Large-scale Reconstructions and Independent, Unbiased Clustering Based on Morphological Metrics to Classify Neurons in Selective Populations
12:27

Large-scale Reconstructions and Independent, Unbiased Clustering Based on Morphological Metrics to Classify Neurons in Selective Populations

Published on: February 15, 2017

6.9K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

1.9K

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Data Science

Background:

  • Opioid use disorder (OUD) presents a global health challenge with evolving patient demographics and biopsychosocial factors.
  • Understanding OUD requires characterizing patient subgroups based on diagnostic criteria.

Purpose of the Study:

  • To identify distinct clusters of individuals with OUD using diagnostic criteria.
  • To reveal clinically relevant subgroups within the OUD population.

Main Methods:

  • Utilized unsupervised clustering analysis on the 11 diagnostic criteria from the DSM-5 for OUD diagnosis.
  • Included 204 male participants in the study.

Main Results:

  • Two primary clusters emerged from the DSM-5 criteria, primarily reflecting OUD severity.
  • Analysis of clinical data alongside DSM-5 criteria identified two groups differing in OUD severity, injecting drug use, and employment status.

Conclusions:

  • Cluster analysis of DSM-5 criteria for OUD revealed two main groups based on numerical aggregation, indicating severity.
  • The findings suggest that OUD symptom clusters are numerically driven by severity rather than symptomatic similarity.